Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugar Balance for Glycemic Variability
NCT03143803Completed
- Sponsor
- Composite Interceptive Med-Science Laboratories
- Start
- May 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Sugar Balance in diabetes mellitus (DM) and prediabetes (2 arms), sponsored by Composite Interceptive Med-Science Laboratories. Primary endpoint: Mean amplitude glycemic excursion at 14 days. Started May 2017; status: completed.
02
Drugs
Sugar Balance
03
Conditions
diabetes mellitus (DM)prediabetes
Beyond the preview
Go deeper on NCT03143803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03143803.